Abstract
Duchenne muscular dystrophy is the most common form of the childhood muscular dystrophies. It follows a predictable clinical course marked by progressive skeletal muscle weakness, lost of ambulation before teen- age and death in early adulthood secondary to respiratory or cardiac failure. Becker muscular dystrophy is less common and has a milder clinical course but also results in respiratory and cardiac failure. Female carriers of both entities are also affected in a variable degree. The natural history of the cardiac involvement in these diseases has not been well established and without screening it progresses asymptomatically until the cardiac reserve has been eroded, when symptoms and signs of cardiac failure emerge. The purpose of this work is to provide recommendations for adequate cardiovascular care in this particular population based on the updated literature as referenced.
Keywords: Neuromuscular diseases, Duchenne muscular dystrophy, Becker muscular dystrophy, cardiovascular care
Current Pediatric Reviews
Title: Cardiovascular Surveillance of Duchenne and Becker Muscular Dystrophy and Female Carriers
Volume: 4 Issue: 3
Author(s): Virginia Spehrs-Ciaffi, Pierre-Yves Jeannet and Nicole Sekarski
Affiliation:
Keywords: Neuromuscular diseases, Duchenne muscular dystrophy, Becker muscular dystrophy, cardiovascular care
Abstract: Duchenne muscular dystrophy is the most common form of the childhood muscular dystrophies. It follows a predictable clinical course marked by progressive skeletal muscle weakness, lost of ambulation before teen- age and death in early adulthood secondary to respiratory or cardiac failure. Becker muscular dystrophy is less common and has a milder clinical course but also results in respiratory and cardiac failure. Female carriers of both entities are also affected in a variable degree. The natural history of the cardiac involvement in these diseases has not been well established and without screening it progresses asymptomatically until the cardiac reserve has been eroded, when symptoms and signs of cardiac failure emerge. The purpose of this work is to provide recommendations for adequate cardiovascular care in this particular population based on the updated literature as referenced.
Export Options
About this article
Cite this article as:
Spehrs-Ciaffi Virginia, Jeannet Pierre-Yves and Sekarski Nicole, Cardiovascular Surveillance of Duchenne and Becker Muscular Dystrophy and Female Carriers, Current Pediatric Reviews 2008; 4 (3) . https://dx.doi.org/10.2174/157339608785856027
DOI https://dx.doi.org/10.2174/157339608785856027 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Potential of Coagonists of Glucagon and GLP-1
Cardiovascular & Hematological Agents in Medicinal Chemistry Vascular Pathology from Smoking: Look at the Microcirculation!
Current Vascular Pharmacology <i>Click</i> Reaction in the Synthesis of Dendrimer Drug-delivery Systems
Current Medicinal Chemistry Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Renin--Angiotensin System Gene Polymorphism and Regression of Left Ventricular Hypertrophy in Hypertension
Current Pharmacogenomics Red Cell Glycolytic Enzyme Disorders Caused by Mutations: An Update
Cardiovascular & Hematological Disorders-Drug Targets Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways
Current Drug Targets - Cardiovascular & Hematological Disorders Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology The Two Faces of Iminoalditols: Powerful Inhibitors Trigger Glycosidase Activation
Current Enzyme Inhibition Amino Acid and Polyamine Membrane Transporters in Trypanosoma cruzi: Biological Function and Evaluation as Drug Targets
Current Medicinal Chemistry Pathogenesis of Age-Related Cataract: A Systematic Review of Proteomic Studies
Current Proteomics Urocortin: Cardiovascular Actions and Therapeutic Implications
Letters in Drug Design & Discovery Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Current Medicinal Chemistry Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology Functional Genomics in Zebrafish as a Tool to Identify Novel Antiarrhythmic Targets
Current Medicinal Chemistry Stress Hormone-Mediated DNA Damage Response -- Implications for Cellular Senescence and Tumour Progression
Current Drug Targets Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology
Current Drug Targets Biology and Regulatory Roles of Nuclear Lamins in Cellular Function and Dysfunction
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery